Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection

Aarogyam UK

Status: Completed

Conditions: Covid19

Treatments: Drug: Guduchi Ghan Vati

Study type: Interventional

Funder types: Other

Identifiers

NCT04542876

AYU/DSSR/03

Details and patient eligibility

About

The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemic.There have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditions.Therefore, present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19

Enrollment: 46 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All hospitalised cases above 18 years of age,
• Diagnosed with Covid-19
• Asymptomatic at the time of admission
• Agree to give consent

Exclusion criteria

• Symptoms relating to Covid-19
• Severe vomiting
• Respiratory failure or requiring mechanical ventilation
• Patients having alanine transaminase (ALT) or aspartate transaminase (AST) > 5 times the upper range of normal limits
• Patients with Covid-19 in critical condition or ARDS or NIAD 8 -point ordinal score-2
• Patients with uncontrolled diabetes mellitus
• Malignant,
• Chronic renal failure or
• On immunosuppressive medication

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

46 participants in 1 patient group

Ayurveda

Experimental group

Description:

Guduchi Ghana is a unique Ayuvedic classical preparation prepared from aqueous extracts of Tinospora cordifolia stem.

Treatment:

Drug: Guduchi Ghan Vati